DK503288D0 - Oxazol- eller thiazolforbindelse, farmaceutisk anvendelse deraf og fremgangsmaade til fremstillig af en saadan forbindelse - Google Patents

Oxazol- eller thiazolforbindelse, farmaceutisk anvendelse deraf og fremgangsmaade til fremstillig af en saadan forbindelse

Info

Publication number
DK503288D0
DK503288D0 DK503288A DK503288A DK503288D0 DK 503288 D0 DK503288 D0 DK 503288D0 DK 503288 A DK503288 A DK 503288A DK 503288 A DK503288 A DK 503288A DK 503288 D0 DK503288 D0 DK 503288D0
Authority
DK
Denmark
Prior art keywords
oxazol
procedure
making
connection
pharmaceutical application
Prior art date
Application number
DK503288A
Other languages
English (en)
Other versions
DK503288A (da
Inventor
Raymond Baker
John Saunders
Roger John Snow
Graham Andrew Showell
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878721343A external-priority patent/GB8721343D0/en
Priority claimed from GB888801759A external-priority patent/GB8801759D0/en
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of DK503288D0 publication Critical patent/DK503288D0/da
Publication of DK503288A publication Critical patent/DK503288A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/468-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK503288A 1987-09-10 1988-09-09 Oxazol- eller thiazolforbindelse, farmaceutisk anvendelse deraf og fremgangsmaade til fremstillig af en saadan forbindelse DK503288A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878721343A GB8721343D0 (en) 1987-09-10 1987-09-10 Therapeutic agents
GB888801759A GB8801759D0 (en) 1988-01-27 1988-01-27 Therapeutic agents

Publications (2)

Publication Number Publication Date
DK503288D0 true DK503288D0 (da) 1988-09-09
DK503288A DK503288A (da) 1989-04-28

Family

ID=26292711

Family Applications (1)

Application Number Title Priority Date Filing Date
DK503288A DK503288A (da) 1987-09-10 1988-09-09 Oxazol- eller thiazolforbindelse, farmaceutisk anvendelse deraf og fremgangsmaade til fremstillig af en saadan forbindelse

Country Status (5)

Country Link
EP (1) EP0307141B1 (da)
JP (1) JPH01151576A (da)
DE (1) DE3877470T2 (da)
DK (1) DK503288A (da)
ES (1) ES2053748T3 (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3789039T2 (de) * 1986-06-27 1994-06-09 Beecham Group Plc Verbrückte bicyclische N-heterocyclische Verbindungen.
ATE133415T1 (de) * 1987-04-15 1996-02-15 Beecham Group Plc Am brückenkopf substituierte azabicyclenderivate
IE63906B1 (en) * 1987-11-13 1995-06-14 Novo Nordisk As Azabicyclic compounds and their preparation and use
EP0322182A3 (en) * 1987-12-22 1992-01-02 Beecham Group Plc Azabicyclic compounds, process for their preparation and pharmaceutical compositions containing them
CA2000041A1 (en) * 1988-10-13 1990-04-13 Barry S. Orlek Compounds
GB8830226D0 (en) * 1988-12-23 1989-02-22 Beecham Group Plc Novel compounds
IT1229491B (it) * 1988-12-28 1991-09-03 Roussel Maestretti S P A Ora R Derivati della 1,2,5,6-tetraidropiridina, loro procedimento di preparazione e loro impiego come sostanze medicinali
DE69030695T2 (de) * 1989-08-16 1998-01-08 Beecham Group Plc Azabicyclische Verbindungen
ATE136031T1 (de) * 1989-10-07 1996-04-15 Beecham Group Plc Azabizyklische verbindungen, verfahren und zwischenprodukte zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
IE912760A1 (en) * 1990-08-06 1992-02-12 Smith Kline French Lab Compounds
CA2096012A1 (en) * 1990-11-29 1992-05-30 Elizabeth Wolde Mussie Intraocular pressure lowering heterocyclic compounds
IE922270A1 (en) * 1991-07-26 1993-01-27 Akzo Nv Pyrazole derivatives
SE9201478D0 (sv) * 1992-05-11 1992-05-11 Kabi Pharmacia Ab Heteroaromatic quinuclidinenes, their use and preparation
EP0749966A4 (en) * 1994-03-11 1997-07-02 Yamanouchi Pharma Co Ltd 5-HT 3 RECEPTOR AGONIST, NEW THIAZOLE DERIVATIVE AND INTERMEDIATE FOR OBTAINING IT
US5733912A (en) * 1997-02-19 1998-03-31 Abbott Laboratories 7A-heterocycle substituted hexahydro-1H-pyrrolizine compounds useful in controlling chemical synaptic transmission
AU5031200A (en) * 1999-05-28 2000-12-18 Vertex Pharmaceuticals Incorporated Method for preparing 5-substituted oxazoles
GB0516313D0 (en) * 2005-08-08 2005-09-14 Argenta Discovery Ltd Azole derivatives and their uses
WO2008017827A2 (en) * 2006-08-08 2008-02-14 Argenta Discovery Limited Azole and thiazole derivatives and their uses
GB0702382D0 (en) * 2007-02-07 2007-03-21 Argenta Discovery Ltd New salt
GB0702385D0 (en) * 2007-02-07 2007-03-21 Argenta Discovery Ltd New combination
GB0702416D0 (en) * 2007-02-07 2007-03-21 Argenta Discovery Ltd New combination
NZ578475A (en) * 2007-02-07 2011-05-27 Pulmagen Therapeutics Synergy Napadisylate salt of a muscarinic m3 antagonist

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5511677B2 (da) * 1971-12-09 1980-03-26
JPS6183170A (ja) * 1984-09-28 1986-04-26 Nippon Chemiphar Co Ltd 新規な1,3−オキサゾリジン−2−オン誘導体およびその製造法
NL8601494A (nl) * 1985-06-22 1987-01-16 Sandoz Ag Thiazolen, hun bereiding en farmaceutische preparaten die ze bevatten.
US4650805A (en) * 1985-12-02 1987-03-17 Warner-Lambert Company 4-(1,2,5,6-Tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamines and 4-(hexahydro-1-alkyl-3-pyridinyl)-2-thiazolamines having anti-psychotic activity
NZ219646A (en) * 1986-03-27 1990-10-26 Merck Sharp & Dohme Oxadiazole derivatives of azacyclics for treating cns disorders
GB8610432D0 (en) * 1986-04-29 1986-06-04 Akzo Nv Amino-thiazole & oxazole derivatives
DE3789039T2 (de) * 1986-06-27 1994-06-09 Beecham Group Plc Verbrückte bicyclische N-heterocyclische Verbindungen.
ATE133415T1 (de) * 1987-04-15 1996-02-15 Beecham Group Plc Am brückenkopf substituierte azabicyclenderivate
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
JP3353406B2 (ja) * 1993-08-16 2002-12-03 富士電機株式会社 燃料電池発電装置

Also Published As

Publication number Publication date
EP0307141A3 (en) 1989-04-12
ES2053748T3 (es) 1994-08-01
DK503288A (da) 1989-04-28
JPH01151576A (ja) 1989-06-14
DE3877470D1 (de) 1993-02-25
EP0307141B1 (en) 1993-01-13
EP0307141A2 (en) 1989-03-15
DE3877470T2 (de) 1993-06-24

Similar Documents

Publication Publication Date Title
DK503288A (da) Oxazol- eller thiazolforbindelse, farmaceutisk anvendelse deraf og fremgangsmaade til fremstillig af en saadan forbindelse
DE68911198D1 (de) Zusammendrückbare feuerfeste Fuge.
NO901132L (no) Bygningselement og en fremgangsmaate for fremstilling av dette.
DK40087D0 (da) Fremgangsmaade til fremstilling af en termoklaeber
DK302187D0 (da) Indretning til fastholdelse af et kateter og fremgangsmaade til fremstilling af samme indretning
DK113088D0 (da) Fremgangsmaade til fremstilling af en thiazepinforbindelse
DK674288D0 (da) Fremgangsmaade til fremstilling af mikrokapsler
DK55191D0 (da) Fremgangsmaade til fremstilling af rekombinerede genprodukter
DK295889D0 (da) Fremgangsmaade til sammenklaebning af materialelag
DK707788A (da) 2,5-diaryltetrahydrofuranforbindelse, praeparat indeholdende en saadan forbindelse og fremgangsmaade til fremstilling af en saadan forbindelse
DK4189D0 (da) Oxadiazolforbindelse, farmaceutisk praeparat indeholdende og fremgangsmaade til fremstilling af forbindelsen
DK581688D0 (da) L-tyrosinderivater og fremgangsmaade til fremstilling af samme
DK138287D0 (da) Fremgangsmaade til fremstilling af ensilage
DK188789D0 (da) N-alkoxy-alkylamidoforbindelse, praeparat indeholdende en saadan forbindelse og fremgangsmaade til fremstilling af en saadan forbindelse
DK64187D0 (da) Enzym-foeler og fremgangsmaade til fremstilling af en saadan
DK102990D0 (da) Thieno-triazolodiazepinderivater, fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse
DK343089A (da) Fremgangsmaade til fremstilling af loebeost
DK336685A (da) 2-benzyl-4-(4-pyridyl)thiazolforbindelse, farmaceutisk praeparat indeholdende en saadan forbindelse og fremgangsmaade til fremstilling af forbindelserne
DK192390D0 (da) Fremgangsmaade til fremstilling af sukkerforbindelser
DK324589D0 (da) Fremgangsmaade til fremstilling af et protein
DK30696A (da) Kapsel til indbringning af lægemidler i kreaturmaver
DK178289D0 (da) Fremgangsmaade til fremstilling af gamma-pyroner
DK711988D0 (da) Methyltetrahydropyridyloxadiazol, farmaceutisk praeparat indeholdende en saadan forbindelse og fremgangsmaade til fremstilling af en saadan forbindelse
DK504988A (da) Fremgangsmaade til fremstilling af makrolidforbindelser
DK505888A (da) Fremgangsmaade til fremstilling af makrolidforbindelser

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment